Azilsartan Medoxomil: A New Angiotensin II Receptor Antagonist for Treatment of Hypertension | Semantic Scholar
Are all sartans equal
Table 4 from Angiotensin-Converting Enzyme (ACE) Inhibitors in Heart Failure:Reducing Mortality and Costs to the NHS | Semantic Scholar
PDF] Initial clinical experience with the first drug (sacubitril/valsartan) in a new class - angiotensin receptor neprilysin inhibitors in patients with heart failure with reduced left ventricular ejection fraction in Poland.
Vergleichstabelle Angiotensin II – Rezeptor Antagonisten (Sartane)
NKF KDOQI Guidelines
NKF KDOQI Guidelines
ATRIUM Cardiology on Twitter: "More data confirm improvement with early initiation of ARNI in patients admitted with ADHF 👇 For more guidance on how to transition from ACEi or ARB to ARNI,
Equivalent dosing of irbesartan, valsartan, and losartan identified through formulary switch at a Veterans Affairs medical center
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) - ScienceDirect
Addition of an Angiotensin II Receptor Blocker to Maximal Dose of ACE Inhibitors in Heart Failure | Revista Española de Cardiología
Defined Daily Doses: Ein Instrument zur Kostensteuerung im Gesundheitswesen?
Are angiotensin-blocking drugs being used in adequate doses? - The British Journal of Cardiology